CHINA PHARMA HLDGS INC - COM (CPHI)

Historical Holders from Q1 2014 to Q1 2023

Type / Class
Equity / COM
Symbol
CPHI on NYSE
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of CHINA PHARMA HLDGS INC - COM (CPHI) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2023 Q1 0 $0 -$87,326 0
2022 Q4 898,253 $87,326 +$30,045 $0.10 7
2022 Q3 584,826 $77,000 -$31,051 $0.13 6
2022 Q2 744,386 $159,000 +$7,609 $0.21 7
2022 Q1 673,176 $262,000 -$79,909 $0.39 10
2021 Q4 879,474 $423,724 -$177,689 $0.48 7
2021 Q3 1,245,429 $695,000 +$73,670 $0.56 6
2021 Q2 1,092,339 $789,000 -$69,448 $0.72 7
2021 Q1 1,189,019 $998,000 +$18,574 $0.84 5
2020 Q4 1,199,903 $534,000 -$22,917 $0.44 8
2020 Q3 1,260,483 $460,000 +$27,747 $0.37 5
2020 Q2 1,164,899 $775,000 +$87,596 $0.66 6
2020 Q1 1,027,686 $518,000 +$30,960 $0.50 3
2019 Q4 1,008,923 $239,000 +$26,627 $0.24 6
2019 Q3 898,712 $220,000 -$37,509 $0.24 6
2019 Q2 998,056 $322,000 -$36,440 $0.32 6
2019 Q1 1,111,131 $368,000 +$92,634 $0.33 5
2018 Q4 893,866 $231,000 +$30,805 $0.26 9
2018 Q3 782,675 $159,000 -$40,531 $0.20 6
2018 Q2 961,691 $210,000 -$40,164 $0.22 8
2018 Q1 1,141,410 $362,000 +$87,323 $0.32 9
2017 Q4 2,547,950 $443,000 -$4,182 $0.18 8
2017 Q3 2,558,155 $446,000 +$41,464 $0.17 6
2017 Q2 2,335,902 $537,000 -$55,411 $0.23 9
2017 Q1 2,577,638 $670,000 +$20,153 $0.26 9
2016 Q4 2,498,705 $650,000 +$5,537 $0.26 7
2016 Q3 2,482,890 $533,000 -$18,663 $0.21 7
2016 Q2 449,773 $109,000 +$18,202 $0.24 6
2016 Q1 2,484,754 $422,000 -$42,050 $0.17 6
2015 Q4 2,760,293 $420,000 -$29,936 $0.16 8
2015 Q3 845,511 $168,000 -$9,192 $0.20 7
2015 Q2 2,997,671 $1,079,000 -$26,217 $0.36 7
2015 Q1 3,070,108 $1,045,000 -$231,837 $0.34 6
2014 Q4 3,757,117 $1,128,000 -$31,276 $0.30 6
2014 Q3 3,859,998 $968,000 +$211,165 $0.25 5
2014 Q2 3,012,882 $1,173,000 -$418,131 $0.38 7
2014 Q1 4,064,243 $2,052,000 -$559 $0.50 7